Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Dellepiane

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Minerva Medica|June 16, 2016
Pathogenesis of nephrotic syndrome after hematopoietic stem cell transplantationsSergio Dellepiane, Davide G Ribaldone
Critical Care (London, England)|March 16, 2016
Detrimental cross-talk between sepsis and acute kidney injury: new pathogenic mechanisms, early biomarkers and targeted therapiesSergio Dellepiane, Marita Marengo, Vincenzo Cantaluppi
Contributions to Nephrology|May 24, 2017
Extracorporeal Treatments in Patients with Acute Kidney Injury and SepsisMarita Marengo, Sergio Dellepiane, Vincenzo Cantaluppi
Nephron|November 1, 2020
Regenerative Role of Stem Cell-Derived Extracellular Vesicles in Acute Kidney InjuryDavide Medica, Sergio Dellepiane, Vincenzo Cantaluppi
Frontiers in Immunology|August 9, 2020
T Cells and Acute Kidney Injury: A Two-Way RelationshipSergio Dellepiane, Jeremy S Leventhal, Paolo Cravedi
Current Opinion in Organ Transplantation|November 10, 2017
ATP and T-cell-mediated rejectionEduardo Castillo-Leon, Sergio Dellepiane, Paolo Fiorina
Critical Care (London, England)|January 24, 2014
Detrimental role of humoral signalling in cardio-renal cross-talkVincenzo Cantaluppi, Sergio Dellepiane, Alessandro D Quercia, et al.
Journal of Nephrology|April 28, 2017
Erratum to: The exciting "bench to bedside" journey of cell therapies for acute kidney injury and renal transplantationSergio Dellepiane, Davide Medica, Alessandro Domenico Quercia, et al.
Journal of Nephrology|March 22, 2017
The exciting "bench to bedside" journey of cell therapies for acute kidney injury and renal transplantationSergio Dellepiane, Davide Medica, Alessandro Domenico Quercia, et al.
Frontiers in Medicine|February 8, 2021
Complement, a Therapeutic Target in Diabetic Kidney DiseaseKelly Budge, Sergio Dellepiane, Samuel Mon-Wei Yu, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Minerva Medica|June 16, 2016
Pathogenesis of nephrotic syndrome after hematopoietic stem cell transplantationsSergio Dellepiane, Davide G Ribaldone
Critical Care (London, England)|March 16, 2016
Detrimental cross-talk between sepsis and acute kidney injury: new pathogenic mechanisms, early biomarkers and targeted therapiesSergio Dellepiane, Marita Marengo, Vincenzo Cantaluppi
Contributions to Nephrology|May 24, 2017
Extracorporeal Treatments in Patients with Acute Kidney Injury and SepsisMarita Marengo, Sergio Dellepiane, Vincenzo Cantaluppi
Nephron|November 1, 2020
Regenerative Role of Stem Cell-Derived Extracellular Vesicles in Acute Kidney InjuryDavide Medica, Sergio Dellepiane, Vincenzo Cantaluppi
Frontiers in Immunology|August 9, 2020
T Cells and Acute Kidney Injury: A Two-Way RelationshipSergio Dellepiane, Jeremy S Leventhal, Paolo Cravedi
Current Opinion in Organ Transplantation|November 10, 2017
ATP and T-cell-mediated rejectionEduardo Castillo-Leon, Sergio Dellepiane, Paolo Fiorina
Critical Care (London, England)|January 24, 2014
Detrimental role of humoral signalling in cardio-renal cross-talkVincenzo Cantaluppi, Sergio Dellepiane, Alessandro D Quercia, et al.
Journal of Nephrology|April 28, 2017
Erratum to: The exciting "bench to bedside" journey of cell therapies for acute kidney injury and renal transplantationSergio Dellepiane, Davide Medica, Alessandro Domenico Quercia, et al.
Journal of Nephrology|March 22, 2017
The exciting "bench to bedside" journey of cell therapies for acute kidney injury and renal transplantationSergio Dellepiane, Davide Medica, Alessandro Domenico Quercia, et al.
Frontiers in Medicine|February 8, 2021
Complement, a Therapeutic Target in Diabetic Kidney DiseaseKelly Budge, Sergio Dellepiane, Samuel Mon-Wei Yu, et al.
Pageof 4